Evaluation of N Nitrosamines - Examining the Tools and Systems to Assist in such Assessments

This 90 minute free to attend webinar presented examples of the very latest in terms of N Nitrosamines. It examined new and evolving regulations as well as looking at specific risk factors and the scientific investigations currently being undertaken to both better understand and contextualise the range of potential risk factors; trying where possible to tease out what is risk and what is not.  In parallel it simultaneously looked at the latest advances in technology to support both research and risk assessment.

Who should view the recording? Chemists / Analysts, Quality Assurance professionals, Regulatory Affairs, Directors / VPs with overall accountability

This webinar was presented by Dr Andrew Teasdale, AstraZeneca. Andrew is the author of over 50 pier reviewed scientific papers as well as two books:

• ICH Quality Guidelines: An Implementation Guide,
• Genotoxic Impurities: Strategies for Identification and Control (published originally in 2010, a much revised second edition is planned for release in early 2021.
• Andrew is also tutor on the 2-day course: Practical management of impurities and development of effective and comprehensive control strategies.

We’d like to thank Anatune, Arcinova, LGC, Lhasa, Spektra Consultoria Brazil and Waters for their kind sponsorship.